IOL CHEMICALS & PHARM. | IND SWIFT LA | IOL CHEMICALS & PHARM./ IND SWIFT LA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.2 | 15.6 | 84.5% | View Chart |
P/BV | x | 1.5 | 1.0 | 146.6% | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. IND SWIFT LA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
IND SWIFT LA Mar-23 |
IOL CHEMICALS & PHARM./ IND SWIFT LA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 77 | 697.0% | |
Low | Rs | 272 | 51 | 532.7% | |
Sales per share (Unadj.) | Rs | 377.6 | 204.3 | 184.8% | |
Earnings per share (Unadj.) | Rs | 23.7 | 8.1 | 292.8% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 17.8 | 177.3% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 115.4 | 222.5% | |
Shares outstanding (eoy) | m | 58.71 | 59.09 | 99.4% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 0.3 | 341.6% | |
Avg P/E ratio | x | 17.1 | 7.9 | 215.7% | |
P/CF ratio (eoy) | x | 12.8 | 3.6 | 356.2% | |
Price / Book Value ratio | x | 1.6 | 0.6 | 283.8% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 3,785 | 627.4% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 1,262 | 133.3% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 12,073 | 183.6% | |
Other income | Rs m | 256 | 335 | 76.4% | |
Total revenues | Rs m | 22,427 | 12,408 | 180.7% | |
Gross profit | Rs m | 2,257 | 2,026 | 111.4% | |
Depreciation | Rs m | 462 | 574 | 80.5% | |
Interest | Rs m | 165 | 922 | 17.9% | |
Profit before tax | Rs m | 1,887 | 865 | 218.0% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 387 | 128.0% | |
Profit after tax | Rs m | 1,391 | 478 | 290.9% | |
Gross profit margin | % | 10.2 | 16.8 | 60.7% | |
Effective tax rate | % | 26.2 | 44.7 | 58.7% | |
Net profit margin | % | 6.3 | 4.0 | 158.4% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 11,631 | 83.1% | |
Current liabilities | Rs m | 5,025 | 3,711 | 135.4% | |
Net working cap to sales | % | 20.9 | 65.6 | 31.9% | |
Current ratio | x | 1.9 | 3.1 | 61.4% | |
Inventory Days | Days | 43 | 10 | 414.8% | |
Debtors Days | Days | 8 | 1,528 | 0.5% | |
Net fixed assets | Rs m | 11,017 | 6,297 | 175.0% | |
Share capital | Rs m | 587 | 598 | 98.2% | |
"Free" reserves | Rs m | 14,490 | 6,221 | 232.9% | |
Net worth | Rs m | 15,077 | 6,819 | 221.1% | |
Long term debt | Rs m | 0 | 7,526 | 0.0% | |
Total assets | Rs m | 20,684 | 17,942 | 115.3% | |
Interest coverage | x | 12.5 | 1.9 | 642.4% | |
Debt to equity ratio | x | 0 | 1.1 | 0.0% | |
Sales to assets ratio | x | 1.1 | 0.7 | 159.3% | |
Return on assets | % | 7.5 | 7.8 | 96.4% | |
Return on equity | % | 9.2 | 7.0 | 131.6% | |
Return on capital | % | 13.6 | 12.5 | 109.2% | |
Exports to sales | % | 26.7 | 73.4 | 36.5% | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | 8,859 | 66.9% | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 8,859 | 66.9% | |
Fx outflow | Rs m | 6,052 | 285 | 2,123.8% | |
Net fx | Rs m | -122 | 8,574 | -1.4% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 1,946 | 62.8% | |
From Investments | Rs m | -1,200 | -134 | 897.7% | |
From Financial Activity | Rs m | -41 | -1,857 | 2.2% | |
Net Cashflow | Rs m | -18 | -44 | 41.8% |
Indian Promoters | % | 48.2 | 42.0 | 114.7% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 19.0 | 8.9% | |
FIIs | % | 1.4 | 0.3 | 451.6% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 58.0 | 89.3% | |
Shareholders | 130,003 | 24,633 | 527.8% | ||
Pledged promoter(s) holding | % | 0.0 | 86.8 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | IND SWIFT LA | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -1.10% | 1.30% | -0.44% |
1-Month | -4.43% | 11.64% | 2.15% |
1-Year | -4.01% | 79.03% | 49.82% |
3-Year CAGR | -11.98% | 19.16% | 14.21% |
5-Year CAGR | 15.37% | 25.97% | 19.19% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the IND SWIFT LA share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of IND SWIFT LA the stake stands at 42.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of IND SWIFT LA.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
IND SWIFT LA paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of IND SWIFT LA.
For a sector overview, read our pharmaceuticals sector report.
After opening the day deep in red, Indian share markets reversed the trend as the session progressed and ended on firm footing.